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We reviewed five studies undertaken by the same research group on the possible links between mi-
tochondrial DNA (mtDNA) variation and asthenozoospermia, all carried out on Tunisian men. A thorough
assessment of these articles reveals that all five studies were carried out on virtually the same cohort of
patients, although this information was concealed by the authors. Thus, the results were ‘sliced’ in order
to unjustifiably maximize the number of publications. In addition, a phylogenetic analysis of their data
indicates that the reported results are notably incomplete and deficient. Overall, contrary to the original
claims, the association of mtDNA variants with asthenozoospermia finds no support on this saga on
Tunisian infertile men.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
During the last few decades, variation in the mitochondrial DNA
(mtDNA) molecule has been studied in the context of many complex
multifactorial diseases [1–9]. In this regard, the search for mtDNA
variation related to infertility has also received the attention of a vast
body of literature [10–16,36]. Some of the positive findings were
critically questioned by others [13,17], who pointed out problems of
different nature, including methodological and theoretical mis-
conceptions, as well as important statistical deficiencies [7,18–21].
For instance, the article by Bandelt [13] questioned the problematic
findings of Holyoake et al. [22] who claimed that carriers of mtDNA
mutations G9055A and G11719A could have their spermmobility and
/ or quantity compromised. Bandelt [13] also pointed to population
stratification problems in the study of Ruiz-Pesini et al. [23] where
the authors found haplogroups H and T significantly more abundant
in non-asthenozoospermic than and asthenozoospermic patients,
respectively. Gómez-Carballa et al. [24] indicated a lack of evidence
for mtDNA variation in infertility, but also showed important defi-
ciencies in the studies of Montiel-Sosa et al. [25] and Feng et al. [26].
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rsidade de Santiago de Com-Tunisian patients where several mutations on the mtDNA molecule
have been proposed to be associated with asthenozoospermia.2. Material and methods
We reviewed five articles published by the same research
group from Tunisia. These articles were published in 2012 [27],
2013 [10,11], and 2014 [12,16]. Note that one of the 2014 papers
[16] was indexed in PubMed using the first names of the authors
instead of the family names, but the authors are virtually the same
and following the same order in the five publications.
Maximum parsimony trees were built using procedures de-
scribed previously [28,29]. Phylotree Build 17 (http://www.phy-
lotree.org) [30] was used as a reference for haplogroup nomen-
clature and worldwide phylogeny. Phylotree and Soares et al. [31]
were also used as references for positional mutational rates.3. Results
3.1. One or five different cohorts?
The articles published in 2012 [27] and 2013 [11] referred to the
analysis of 66 patients, of which 32 were normospermic and 34
asthenozoospermic. In the 2013 article [11], the authors also
mentioned an age range for patients of 23–57 years. In the othernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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normospermic and 31 asthenozoospermic, again in the range of
23–57 years of age (as stated in two of these three articles). All the
patients in the five publications were from the same geographic
origin (Tunisia).
The almost complete overlap in sample sizes, age ranges, and
geographic origin, strongly support the hypothesis that the au-
thors used always the same cohort (with a minor difference in
sample size). Moreover, variants reported in the five articles
overlap to a great extent (see below). It is however surprising that
none of the articles mentioned this issue, therefore conveying the
impression that in reality five different and independent cohorts
were considered – one per article. It is also remarkable that only
one article from 2013 [10] cited the 2012 article [27] (although not
in regards to the cohorts), while there are no cross-references
among the rest of the articles. This is most noteworthy if we
consider that the aims of the five articles were exactly the same,
and all of them were carried out on Tunisians.
Baklouti-Gargouri et al. also mention in the different publica-
tions the use of a control group of fertile men in order to in-
vestigate the incidence of their candidate mutations in healthy
individuals. The sample size for this control group is 100 in the
three initial publications [10,11,27]; it grew to 150 in Baklouti-
Gargouri et al. [12], and for some unexplained reason, these con-
trols were omitted in the last publication from 2014 [16]. Cur-
iously, in this latter publication, the authors used their normos-
permic infertile men as controls. In all five publications, controls
were used exclusively to claim that their best candidate causal
mutation was not present in their controls; e.g. “This mutation
[m.8021A4G] was absent in normospermic patients, suggesting that
it could be associated to asthenospermia” [16]. Association tests
were never carried out, nor estimates of risk for their candidate
variants.
3.2. Five ‘salami slicing’ papers?
In the best cases, the reviewed articles reported only a list of
mtDNA variations observed in the studied patients, but never the
full list of haplotypes obtained. This is against best practice stan-
dards for mtDNA studies, which recommend to report the full
results [32]. The information provided by the authors is therefore
very limited so it is not possible to fully reconstruct the overlap
existing between the different studies and the overall scenario.
However, a number of inferences can be made from the available
data.
Thus, there are some disconcerting issues in the five Tunisian
studies. First, the articles published in 2012 [27] and 2013 [10]
targeted COXI, the article from 2014 [12] only COXIII, while the
other two articles targeted the COXI, COXII, COXIII, ATP6, ATP8, and
CYTB genes (Table S1). For instance, COXI was sequenced in four
out of the five studies. The study from 2012 [27] reported only the
association of A6375G with asthenozoospermia. In contrast, the
study from 2013 [10] reported 21 variants within COXI gene that
do not include the previously reported A6375G (note also that
their variant G7521A does not really fall within COXI, see below);
20 out of these 21 variants fully overlap with those reported in
2014 [16], when the authors added A6307G to the pool, claiming
its novelty and association with the disease. In general, there is
extensive overlap of variants between the different studies, even
in those with low or very low mutation rate (i.e. A9425G and
A9390G, with no hit either in Phylotree or in Soares et al. [31]; see
Table S2), adding definitive support to the hypothesis that the
authors used virtually the same cohort. The few exceptions would
be the novel and allegedly pathogenic mutations that were re-
ported in exclusive in each paper.3.3. ‘Infertile’ mitochondrial DNA data
In the five publications, the authors reported a total absence of
their candidate mutations in controls, contrasting with the high
frequency of these mutations in their patients, ranging from 8.8%
to 100% (mutation G9588A in the 2014 article [16]). Although the
authors never estimated the risk associated to these mutations,
such risk would be so exceptionably high in the context of a
multifactorial disease that it has to be called into question. If we
accept the likely hypothesis that the authors used virtually the
same cohort for the five publications, we can formulate further
puzzling questions. For instance, if G9588A appears in all the pa-
tients in the 2014 paper [12], why did this mutation not show up
in the other studies where the same region (COXIII) was analyzed
[11,16]? The same question applies to other mutations reported in
their papers. In an alternative, very unlikely scenario, assuming
five different cohorts instead of one, it would still be very odd to
have failed to observe these mutations in previous patients before
finding them in 100% of the patients in the 2014 cohort.
In addition, the data reported by these authors contain many
inconsistencies. To mention some examples, Table 2 in the 2014
study [16] shows the number of “polymorphisms SNPs in the
asthenozoospermic and normozoospermic infertile patients”. The
total numbers in this table make no sense (for instance, gene COXI:
there are 25 SNPs in asthenospermic patients, 0 in normospermics,
but 0 in asthenospermicsþaormospermics). In the 2013 article
[11] polymorphism T9540C is reported twice out of the seven
polymorphism listed within COXII; and the same occurs with
transitions C14766T and T6221C of CytB and COXI, respectively, in
Table 3 of Siwar et al. [16]. In this table [16], transition T6221C was
described as “reported in mitomap” but also, in another row of the
same table, as “novel”. Interestingly, this transversion had already
been reported in two of the previous publications without as-
signing novelty status to it [10,11]. It should be noted that tran-
sition T6221C is a diagnostic position of haplogroup X and it ap-
pears in many other haplogroups of the worldwide mtDNA phy-
logeny (at least nine); this variant appeared dozens of times in the
literature before the publication by Baklouti-Gargouri et al.;
therefore, T6221C was definitely not novel at the time of these
publications. Other examples of novelty misallocation are muta-
tions A8413G, reported in Baklouti-Gargouri et al. [11] (e.g. two
hits in previously published paper of Soares et al. [31]), or C6146T,
C6296A, and T6614C, reported as novel in Siwar et al. [16] (e.g. all
received one hit in Soares et al. [31]).
There are also a number of errors of misallocation of reference
nucleotides in some of the reported polymorphisms. For example,
in Fig. 1 of [11] they report a transition T7724C located in COXII
gene (T-A amino acid change); however, the rCRS nucleotide at
position 7724 should be an “A”; in the same Figure, the variant
G8248A should have been reported as A8248G in order to be
consistent with nomenclature.
Turning to other problematic issues, the primer pairs used by
the authors to amplify the Cytb gene (primers m-22F and m-22R)
were identical in Baklouti-Gargouri et al. [11] and in Siwar et al.
[16] (see their Tables 1); these primers cover a sequence range
from position 14856–15978 of the mtDNA molecule, and produce a
PCR amplicon of size 1162 bp. Nevertheless, the authors reported
two transitions out of this range, namely, C14766T and T14783C, in
Siwar et al. [16] but not in Baklouti-Gargouri et al. [11]. Both tables
are almost identical (including legend), with only one difference:
Table 1 from Siwar et al. [16] does not show the start and end of
the PCR products.
In the same line, the primer pairs used to amplify COXI gene in
Baklouti-Gargouri et al. [10] cover a sequence range from 5855 to
7315; however, they indicated the presence of G7521A (which is
out of the amplicon). Moreover, G7521A is not really located in
Fig. 1. Reconstruction of the phylogeny of the partial haplotypes inferred from the data in Baklouti-Gargouri et al. [11]. Note that the data reported were incomplete, and
therefore this phylogeny might also be incomplete. Only diagnostic positions that fall within the PCR amplicons used by the authors were considered. Mitochondrial DNA
variations are displayed along branches; the rCRS was used as standard for nomenclature [35]. All variants are transitions unless a suffix specifies a transversion (A, C, G, T),
or a deletion (d). Mutations displayed in black were reported by the authors while in red are the variants that are missed according to the known phylogeny. Recurrent
mutational events are underlined. A prefix “@” indicates a back mutation. Blue dots accompanying mutations indicate those that appear only once in Phylotree.
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and Table 3 of Siwar et al. [16], but in the mt-TD gene (tRNA-Asp).
Additionally there are two mutations reported by the authors as
novel in Table 3 of Baklouti-Gargouri et al. [11], namely, mutations
T7572C and A8312G; these polymorphisms were again incorrectly
allocated to a non-coding region, but in fact they fall in the genes
that encode for tRNA-Asp and tRNA-Lys respectively.Finally, based on the known mtDNA phylogeny, there are a
number of polymorphisms that should have been found according
to the amplicons analyzed by the authors, but which were how-
ever not reported in their lists of variants. Figs. 1 and 2 present and
attempt at reconstructing the mtDNA phylogeny of the haplotypes
inferred from the data reported in Baklouti-Gargouri et al. [11] and
Siwar et al. [16], respectively, using the most parsimonious
Fig. 2. Reconstruction of the phylogeny of the partial haplotypes inferred from the data in Siwar et al. [16]. Only diagnostic positions that fall within the PCR amplicons used
by the authors were considered, with the exception of variants C14766T and T14783C, reported out of PCR coverage range (see text above). See legend to Fig. 1 for more
details.
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thors never published the complete haplotypes (but only lists of
variants). There is no doubt that the existence of some branches
can be inferred with full confidence: most of the variants along the
branches have a very low mutation rates (75% of them fall below
5 hits in Phylotree); Table S2. Moreover, some mutations appear
only once in Phylotree and therefore unambiguously identify one
single haplogroup.
According to these phylogenies, the variants that were missed
in Baklouti-Gargouri et al. [11] exceed by far the list of published
variants (Fig. 1). To give an example, the four polymorphisms that
determine the path from the rCRS to haplogroup R0 were alto-
gether missed, although these variants were all reported in the
next publication by Siwar et al. [16] (Fig. 2). Another clear example
concerns haplogroup L3k1; it is signaled in the data of Baklouti-
Gargouri et al. [11] by diagnostic variants A8649G (one hit),
T6620G (one hit) and G15314A (leading from L3e′i′k′x4L3k), and
A9007T (one hit; L3k4L3k1); however, two other diagnostic
variants in the same branch were missed, namely, T9467C (L3e′i′k′
x4L3k), and G9329A (L3K4L3k1).
There are also numerous instances of missing data in Siwar
et al. [16]. For instance, there is a series of unique variants that
undeniably led to branch L1b. These variants are C8655T (L2′3′4′6),
A7146G (L2′3′4′5′6), A6989G, and A8248G (L1b); this path isadditionally supported by several other variants in the data that
also have low mutation rates (C8468T, A9389G, etc). However,
variant C6548T (leading from L1 to L1b) is absent from the pub-
lished list; Fig. 2.
In addition, there seem to be some methodological problems
affecting not only particular variants but also relatively large se-
quence segments (even though these segments were supposedly
covered by the indicated amplicons). For instance, in the article by
Baklouti-Gargouri et al. [11], no variants were reported for the
sequence segments 14856–15203 and 15488–15978 (totaling
837 bp; that is, the authors only reported variants within a seg-
ment of 285 bp out of an amplicon size of 1162 bp), while in the
article from Siwar et al. [16], no variants were noted for the seg-
ment 8868–9300 (432 bp).4. Discussion
Previous studies have already revealed important deficiencies
in studies dealing with mtDNA variation and infertile men [13].
Here we examined a series of articles on male infertility that were
published by the same research group. A thorough analysis of the
articles indicates that the authors used always the same cohort of
patients, although this aspect is not mentioned in their
A. Salas et al. / Biochemistry and Biophysics Reports 8 (2016) 114–119118publications. Their findings appear to have been split in order to
maximize the number of publications without justification. The
series of articles by Baklouti-Gargouri et al. might be interpreted
as an example of “salami slicing” papers, a practice that is widely
considered unethical by editors and overall by the scientific
community.
Analysis of the literature on mtDNA variation in infertility has
also revealed an important publication bias, which is not unusual
in mtDNA disease studies [33]. The critical review by Bandelt [13]
in regards to the Holyoake et al. [22] article received only 7 cita-
tions (Google Scholar, queried on March 2016), while the Holyoake
et al. paper has received 89 citations. The article by Montiel-Sosa
et al. [25], critically investigated by Gómez-Carballa et al. [24], was
cited 86 times. The only exception of a paper with negative find-
ings that was highly cited (55 times) was Pereira et al. [34];
however, less than a quarter of these citations were related to
infertility, while the rest were justified by the phylogenetic inter-
est of their data in a human population context.
Overall, the few articles claiming an association between
mtDNA variation and infertility do not rest of solid grounds. The
present study has contributed to argue in this direction, while it
constitutes an effort to reveal problems of different nature in the
literature on infertility research, including scientific misconduct.Acknowledgments
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